Summary It has been generally accepted that transforming growth factor 31 (TGF-j1l) has both negative and positive effects on tumour growth and progression. This study analysed the prognostic value of TGF-1l mRNA in advanced gastric carcinoma. A reverse transcriptase-polymerase chain reaction analysis (RT-PCR) was used for TGF-J1 in endoscopic biopsy specimens from 42 advanced gastric carcinomas. Thirty specimens expressed TGF-p1 mRNA while 12 specimens did not. The follow-up duration ranged from 4 to 37 months (mean 22.8 months). TGF-31 -positive group demonstrated a shorter overall survival compared with the TGF-p1 -negative group (P= 0.0014).
It has been suggested that adxanced oastric carcinomas may be dix-ided into poor and good prognostic groups. Recent studies of Various types of tumours hax-e stronglx suggested that the malignant potential of tumours can be correlated with gene expression (Tahara et al. 1986 ). Here. we focused on the preoperative evaluation of the malignant potential of gastric carcinoma related to mRNA expression of tumour growth-related factors at the tumour site (Nakamura et al. 1997) . In advanced cases. mRnNA expression for transformin, growth factor-Pl (TGF-P11) showxed a significant positive correlation w ith nodal involvement (Nakamura et al. 1997) . Traditional clinicopatholocical studies have show-n that l-mph node involx ement is an important risk factor for predictinc overall survixal (Maruvrama et al. 1989 : Jatzko et al. 1995 . These obserxations suggest that TGF-1 mRNA expression in biopsy specimens may identify a subgroup of gastric carcinoma patients with verx acgressive disease.
TGF-3 has a dimeric structure with a molecular weight of 25 kDa (Assoian et al. 1983) . It has been demonstrated that there are three forms in humans: TGF-,B1. TGF-12 and TGF-13. with TGF-,13 beincg the most prevalent (Miyazono et al. 1988 ). TGF-,B1 is a potent inhibitor of epithelial cell growth (Masui et al. 1986 : Coffey et al. 1988 ).
How-ever. carcinoma cells. unlike normal cells. can escape from neg,ative reaulation by TGF-PI at the post-transcriptional (Fow-lis et al. 1992 : Cui et al. 1994 . receptor (Kimichi et al. 1988 al. 1990 : Laiho et al. 1990 : Pietenpol et al. 1990 : Ito et al. 1992 ). Cui et al (1994) have suggested that highly malignant carcinomas. especially advanced cases. may not be inhibited by TGF-p1. and post-transcriptional down-regulation of TGF-J1 production may enhance tumour growth. They have also sugaested that once tumour cells are refractorx to grow-th regulation. TGF-11 expression may confer a selectixe advantage to the tumour bv enhancing angiogenesis or modulating stromal characteristics or the immune response to tumour growth. thus leading to increased invasion and metastasis (Torre-Amione et al. 1990 : Welch et al. 1990 ). On the basis of these previous data. w e hypothesized that TGF-,13 expression at the site of carcinoma. especially advanced tumours. may contribute to highlx malignant behaviour. Figure 2 Overall survival curves of the 42 patients with advanced-stage gastric carcinoma, according to the expression of TGF-1l mRNA in the carcir*rna specimens. The P-value was determined using the log-rank test Figure 3 Overall survival curves of the 32 patients with advanced gastric carcinora patients who underwent a curative resection. The P-value was determined using the log-rank test TGF-Pl-negative group (P = 0.0014) (Figure 2 ). Multivariate analysis indicated that TGF-,B1 mRNA expression (P = 0.0186) was a significant independent prognostic factor ( Table 2 ). The prognosis of the 32 advanced carcinoma patients w%ho underwent curative resection was studied. Overall survival of the 20 TGF-41-positixe patients was worse than that of the 12 TGF-01-negative patients (P = 0.0048) (Figure 3 ). Significant correlations were found between TGF-,B1 mRNA expression and both stage (P = 0.0015 ) and nodal involvement (P = 0.0060) ( Table 3) . Multivariate analvsis also demonstrated that only TGF-f1 mRNA expressio (P = 0.0306) was an independent prognostic factor (Table 4) . Ten patients underwent non-curatixe resection because of peritoneal dissemination (four cases). hepatic metastasis (five cases) or oxarian metastasis (one case) ( Table 5 ). All of these carcinoma specimens expressed TGF-4 1 mRNA.
MATERIALS AND METHODS
British Joumal of Cancer (1998) 78(10), [1373] [1374] [1375] [1376] [1377] [1378] -_ TGF-pl (-) (ri--12) .-ALL--Li (Nakamura et al. 1997) . In the present study. TGF-P1 mRNA expression similarly showed a positise correlation with lymph node disease. In addition. the TGF-Pl-positive patient had a shorter overall survival compared s ith TGF-P 1-negative patients who underwent gastrectomrv or curative resection. Although we hy pothesized that poor prognosis in TGF-1 positive cases resulted from lymph node involvement. multisariate analvsis indicated that transcnption of TGF-1 1. not nodal status. was a prognostic factor. This findinc may explain why tumours recur in some patients without nodal involvement. One possibility is that TGF-51 mRNA levels in carcinoma specimens may predict ly mph node metastasis. esen when consentional histological examination is necative (Hayashi et al. 1995 : Maehara et al. 1996 . Another is that the determination of TGF-J31 mRNA may be independent of the traditional pathological characteristics predicting, sun ival.
TGF-P is a prototype of multifunctional growsth factors that either inhibit or stimulate cell proliferation (Mackay et al. 1995) . In vitro studies using cell lines have demonstrated that TGF-1 inhibits the growth of most epithelial cells (Masui et al. 1986 : Coffey et al. 1988 ). includinc, colon carcinoma (Hoosein et al. 1987 ) and gastric carcinoma (Ito et al. 1992) . Little is knoswn. however. about the association of TGF-3 with progression of malignant diseases in svisvo. Recent observations have demonstrated that TGF-3 may facilitate tumour growth through immunosuppression. angiogenesis or changes in the extracellular matrix (Pepper et al. 1990 : Kehrl et al. 1991 : Tada et al. 1991 : Ueki et al. 1992 ) Several studies have demonstrated high levels of TGF-PI mRNA in gastric carcinoma (Tahara. 1990 : Hiravama et al. 1992 . especially the scirrhous type (Yoshida et al. 1989) . We have previously examined TGF-11 mRNA in surgically resected primary gastric carcinomas (Morisaki et al. 1996) . We have reported that TGF-41 mRNA was frequently expressed in poorly differentiated adenocarcinomas and in tumours wvith an advanced stage or lvmph node spread (Morisaki et al. 1996 ). An association betw-een TGF-11 mRNA expression with metastatic spread to axillary lymph nodes has been shown in breast cancer (Walker and Dearina. 1992 ). Tsushima and colleagues (1996) have reported that TGF-11 expression may be associated s ith colorectal adenocarcinoma invasiveness (Tsushima et al. 1996 .) Friess and colleagues (1993) have demonstrated that human pancreatic cancers have increased levels of TGF-, isoforms and suggested that TGF-3 may contribute to disease progression (Friess et al. 1993 ).
We suggest that investigation of TGF-1 mRNA in carcinoma specimens may be a new tool for the preoperative evaluation of the aggressise potential of gyastric carcinoma. The present study showed a significant correlation bettween expression of TGF-11 mRNA in castric carcinoma specimens and a poor prognosis. Similar results have been reported in other types of solid tumours. Takanami and colleagues (1994) have demonstrated that TGF-I1 was an independent prognostic indicator in patients with pulmonary adenocarcinoma (Takanami et al. 1994 ). Gorsch and colleagues (1992) described an association between the intensity of TGF-31 immunoreactisity in breast carcinoma specimens and disease-free survival that was independent of established prognostic variables (Gorsch et al. 1992) . Because TGF-11 mRNA may be elevated in normal tissue adjacent to tumour tissue (Anzano et al, 1985; Travers et al, 1988; Gomella et al, 1989) . it remains unclear whether gastric carcinoma cells are the main source of TGF-5l in our study. We have shown that TGF-]1 mRNA was expressed more frequently in carcinoma tissues than in adjacent normal cells (Morisaki et al, 1996) . We confirmed that TGF-01 protein was expressed in the tumour cells of five TGF-j1 -positive carcinoma specimens determined by RT-PCR (data not shown). We postulate that TGF-I1 produced by gastric carcinoma cells may act as a growth factor for the tumour through autocrine and paracrine loops.
TGF-0 action is tightly regulated through transcriptional control (Kim et al, 1989a and b) . It is possible that highly malignant carcinomas lose the inhibitory response to TGF-(1 (Torre-amione et al, 1990; Welch et al, 1990; Gorsch et al, 1992; Eklov et al, 1993; Glick et al, 1993; Jirtle et al, 1993; Cui et al, 1994) . Some carcinoma cells may escape negative regulation by TGF-0 through post-transcriptional down-regulation of TGF-0 production (Fowlis et al, 1992; Cui et al, 1994) . Other carcinomas may escape at the receptor (Kimchi et al, 1988) or post-receptor level (Braun et al, 1990; Laiho et al, 1990; Pietenpol et al; 1990; Ito et al, 1992) . It is also possible that autocrine or paracrine stimulation of carcinoma cell proliferation by TGF-5l may directly influence progression of gastric carcinoma. Leof and colleagues (1986) have demonstrated a positive growth response to TGF-01 (Leof et al, 1986) .
TGF-01 mRNA expression significantly correlated with the presence of involved lymph nodes. Extended gastrectomy including D3 or D4 lymph node dissection may be recommended for improved survival in TGF-0l-positive cases.
